학력

• 2022.02

  성균관대학교 의학과 박사 수료

• 2016.02

  이화여자대학교 의학과 석사

• 2011.02

  서강대학교 생명과학과 학사

주요경력

• 2024.03 ~ 현재

  인하대병원 소아청소년과 조교수

• 2023.03 ~ 2024.02

  인하대병원 소아청소년과 임상조교수

• 2020.03 ~ 2023.02

  삼성서울병원 소아청소년과 소아소화기영양 임상강사

• 2016.03 ~ 2020.02

  삼성서울병원 소아청소년과 전공의

• 2015.03 ~ 2016.02

  삼성서울병원 인턴

학회활동

• -

  대한소아소화기영양학회 정회원

• -

  대한소화기내시경학회 정회원

• -

  대한소아청소년과학회 정회원

수상경력

• 2022.06

  아시아염증성장질환학회 우수포스터상 수상

• 2022.05

  대한장연구학회 국제학술대회 젊은 연구자상 수상

• 2020.10

  대한소아청소년과학회 GSK 우수 초록상

주요 논문 및 저서

• 2023

  Choi, S. Y., Kwon, Y., Choi, S., Lee, S. M., Choe, B. H., & Kang, B. (2023). Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease. Frontiers in Immunology, 14.

• 2023

  Lee, H. C., Kwon, Y., Kim, E. S., Ahn, S., Choe, Y. H., & Kim, M. J. (2023). Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum. Annals of Dermatology, 35.

• 2023

  Noh, H. S., and Kwon, Y. "Spontaneous pneumomediastinum induced by electronic cigarette use that could have been mistaken for secondary pneumomediastinum due to underlying Crohn’s disease." 대한응급의학회지 34.5 (2023): 462-466.

• 2023

  Ahn, Y. J., and Kwon, Y. Co-occurrence of leukemia, Crohn’s disease, and tuberous sclerosis in one patient. Precision and Future Medicine 2023; 7(4): 155-158.

• 2022

  Kwon Y., Kim YZ, Choe YH, Kim MJ. Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission. Frontiers in Immunology, 2022;13.

• 2022

  Kwon Y., Kim ES, Kim YZ, Choe YH, Kim MJ. Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn’s Disease. Biomedicines, 2022;10(10), 2372.

• 2022

  Kwon Y., Kim ES, Choe YH, Kim MJ. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World Journal of Gastroenterology, 2022;28(28), 3666.

• 2022

  Kwon Y., Kang B., Kim ES, Choe YH, Kim MJ. Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn’s Disease. Therapeutic Drug Monitoring, 2022;44(4), 535.

• 2022

  Kwon Y., Kim ES, Choe YH, Kim MJ. Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations. Frontiers in Pediatrics, 2022;10.

• 2022

  Kwon Y., Kim ES, Choe YH, Kim MJ. Stratification by non-invasive biomarkers of non-alcoholic fatty liver disease in children. Frontiers in Pediatrics, 2022;10.

• 2021

  Kwon Y., Kim MJ. The update of treatment for primary intestinal lymphangiectasia. Pediatric Gastroenterology, Hepatology & Nutrition, 2021;24(5), 413.

• 2021

  Kwon Y., Kim ES, Choe YH, Hyun D., Kim MJ. Therapeutic lymphatic embolization in pediatric primary intestinal lymphangiectasia. Yonsei Medical Journal, 2021;62(5), 470.

• 2021

  Kwon Y., Kim ES, Choe YH, Kim MJ. Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature. BMC pediatrics, 2021, 1-9.

언론보도